Allodynic Therapeutics Competitors and Similar CompaniesClear all
Allodynic Therapeutics's competitors and similar companies include GBT (Global Blood Therapeutics), Kamada Pharmaceuticals, JCR Pharmaceuticals and Heron Therapeutics.
 Allodynic Therapeutics Allodynic Therapeutics is a pharmaceutical company that develops low-dose naltrexone-based products. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications. |  JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. |  Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. | |
Founding Date | Founding Date 2010 | Founding Date 2012 | Founding Date 1990 | Founding Date 1975 | Founding Date 1983 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations North Miami, US HQ | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations Rehovot, IL HQ Beit Kama, IL | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP | Locations San Diego, US HQ |
Employees | Employees 325% decrease | Employees 352106% increase | Employees 420 | Employees 934 | Employees 20333% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.4 b | Valuation ($) 317 m | Valuation ($) 533.9 m | Valuation ($) 268.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $180.5m (FY, 2025) | Revenue (est.) ¥33.1b (FY, 2025) | Revenue (est.) $154.9m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $3.3m (FY, 2021) | Cost of goods $72.1m (FY, 2025) | Cost of goods ¥8b (FY, 2025) | Cost of goods $41.3m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $108.4m (FY, 2025) | Gross profit ¥25.1b (FY, 2025) | Gross profit $113.6m (FY, 2025) |
Net income | Net income N/A | Net income ($303.1m) (FY, 2021) | Net income $20.2m (FY, 2025) | Net income (¥4.7b) (FY, 2025) | Net income ($20.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 88.7m | Total funding raised $ 90m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyKamada Pharmaceuticals
HQ
Rehovot, IL
Employees
420
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
View companyJCR Pharmaceuticals
HQ
Ashiya, JP
Employees
934
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
View companyHeron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View company